MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MP-16-0006486
Religrace Parentral India Private Limited
Religrace Parentral India Private Limited - pharma in Dewas, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.11 Cr
Latest filing
Net profit · FY 2025
₹43.37 Lakh
Net margin 3.6%
EBITDA · FY 2025
₹2.84 Cr
EBITDA margin 23.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹3 Cr
Issued & subscribed
Open charges
₹17.51 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
7
Provident fund records
About Religrace Parentral India Private Limited
Data last updated:
Religrace Parentral India Private Limited is a private limited company based in Dewas, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2021PTC056574. Its GSTIN is 23AALCR1120J1ZO (Madhya Pradesh).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Prabhu Dayal Sharma and Mamta Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 11 Laxman Nagar, Dewas, Madhya Pradesh, India – 455001.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.11 Cr. For the same year it recorded a net profit of ₹43.37 Lakh (net margin 3.6%) and EBITDA of ₹2.84 Cr (EBITDA margin 23.4%).
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹17.51 Cr on record.
Religrace Parentral India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MP-16-0006486).
Company details
CIN U24230MP2021PTC056574
Registration Number 056574
Incorporation Date 06 July 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification MSME
Udyam Registration UDYAM-MP-16-0006486
Recognitions & Rankings of Religrace Parentral India
Contact details
Religrace Parentral India Private Limited's registered office is in Dewas, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address11 Laxman Nagar, Dewas, Madhya Pradesh, India – 455001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Religrace Parentral India Private Limited, buy the company report.
Comprehensive company report
Religrace Parentral India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Religrace Parentral India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Religrace Parentral India Private Limited, buy the company report.
Financials of Religrace Parentral India Private Limited
FY 2024 filings availableReligrace Parentral India Private Limited reported revenue of ₹12.11 Cr for FY 2025.
Revenue · FY 2025
₹12.11 Cr
Net profit · FY 2025
₹43.37 Lakh margin 3.6%
EBITDA · FY 2025
₹2.84 Cr margin 23.4%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.84 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹43.37 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 23.4% | |||
| Net Profit Margin | 3.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Religrace Parentral India Private Limited, buy the company report.
Board of directors of Religrace Parentral India Private Limited
Religrace Parentral India has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhu Dayal Sharma | Director | 06 Jul 2021 | 5 Years 4 Months | Current |
| Mamta Sharma | Director | 06 Jul 2021 | 5 Years 4 Months | Current |
| Manoj Sharma | Director | 06 Jul 2021 | 5 Years 4 Months | Current |
Peer comparison
Religrace Parentral India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Francis Remedies (India) Private Limited | ₹12.19 Cr (FY 2024) | 38.0% | Delhi, India | |||
| Mac Organics Pvt.Ltd. | ₹12.15 Cr (FY 2023) | 2.0% | Panvel, Maharashtra, India | |||
| Tanishka Pharmaceuticals Private Limited | ₹12.13 Cr (FY 2025) | -14.0% | Solan, Himachal Pradesh, India | |||
| Religrace Parentral India Private Limitedthis company | ₹12.11 Cr (FY 2025) | ₹43.37 Lakh | 3.6% | Dewas, Madhya Pradesh, India | ||
| Kayvee Aero Pharm Pvt Ltd | ₹12.1 Cr (FY 2025) | 77.0% | Kadi, Gujarat, India | |||
| Abhimantrit Guruprasadam Ayurveda Herbal Foods Private Limited | ₹12.06 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Hilsun Foods and Drugs Private Limited | ₹12.06 Cr (FY 2024) | 29.0% | Thane, Maharashtra, India |
To see the full peer comparison of Religrace Parentral India Private Limited, buy the company report.
Auditor
Religrace Parentral India Private Limited is audited by Ajit Jain & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ajit Jain & Co. | FY 2024 | 006199C |
Shareholding
The shareholding of Religrace Parentral India Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Religrace Parentral India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.51 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jun 2025 | 101130832 | Others | ₹2.35 Cr | Open | |
| 05 Oct 2024 | 101022754 | Hdfc Bank Limited | ₹16 Lakh | Open | |
| 29 Dec 2021 | 100528431 | Others | ₹15 Cr | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Religrace Parentral India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Religrace Parentral India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Religrace Parentral India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AALCR1120J1ZO | Madhya Pradesh | Active | 15 Nov 2021 |
To see the full GST registrations and return filing status of Religrace Parentral India Private Limited, buy the company report.
Recent activity
Religrace Parentral India Private Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Mubarik Khan ceased to be Director on 28 Mar 2024.
Charges
A charge with Others amounted to Rs. 2.35 Cr with Charge ID 101130832 was registered on 11 Jun 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.16 Cr with Charge ID 101022754 was registered on 05 Oct 2024.
AGM
Religrace Parentral India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Religrace Parentral India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Ceased
Mubarik Khan ceased to be Director.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100528431 was registered on 29 Dec 2021.
Appointed
Mamta Sharma was appointed as Director.
Appointed
Manoj Sharma was appointed as Director.
Appointed
Manoj Sharma was appointed as Director.
Appointed
Prabhu Dayal Sharma was appointed as Director.
Incorporation
06 Jul 2021
Religrace Parentral India Private Limited was registered on 06 Jul 2021 with Roc Gwalior & aged 5 years 4 months as per MCA records.
Frequently asked questions
Religrace Parentral India is an active private limited company based in Dewas, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 July 2021 (5+ years old) and is registered under CIN U24230MP2021PTC056574.
Religrace Parentral India has 3 current directors:
- Prabhu Dayal Sharma - Director
- Mamta Sharma - Director
- Manoj Sharma - Director
The latest financial statements of Religrace Parentral India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Religrace Parentral India is 23AALCR1120J1ZO, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Religrace Parentral India is U24230MP2021PTC056574. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Religrace Parentral India was incorporated on 06 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Religrace Parentral India by revenue are Francis Remedies (India) Private Limited, Mac Organics Pvt.Ltd, Tanishka Pharmaceuticals Private Limited, Kayvee Aero Pharm Pvt Ltd, Abhimantrit Guruprasadam Ayurveda Herbal Foods Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mubarik Khan ceased to be Director on 28 Mar 2024. Mamta Sharma was appointed as Director on 06 Jul 2021. Manoj Sharma was appointed as Director on 06 Jul 2021. Religrace Parentral India has 5 board changes on record in total.
Yes, Religrace Parentral India is registered as an MSME under Udyam registration (number: UDYAM-MP-16-0006486).
The registered office of Religrace Parentral India is at 11 Laxman Nagar, Dewas, Madhya Pradesh, India – 455001.
Religrace Parentral India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages